Daniel P. Judge

37.5k total citations · 7 hit papers
220 papers, 16.1k citations indexed

About

Daniel P. Judge is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Genetics. According to data from OpenAlex, Daniel P. Judge has authored 220 papers receiving a total of 16.1k indexed citations (citations by other indexed papers that have themselves been cited), including 133 papers in Cardiology and Cardiovascular Medicine, 76 papers in Molecular Biology and 43 papers in Genetics. Recurrent topics in Daniel P. Judge's work include Cardiovascular Effects of Exercise (83 papers), Cardiomyopathy and Myosin Studies (52 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (45 papers). Daniel P. Judge is often cited by papers focused on Cardiovascular Effects of Exercise (83 papers), Cardiomyopathy and Myosin Studies (52 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (45 papers). Daniel P. Judge collaborates with scholars based in United States, Netherlands and Italy. Daniel P. Judge's co-authors include Harry C. Dietz, Hugh Calkins, Cynthia A. James, Jennifer Habashi, Crystal Tichnell, Bart Loeys, Loretha Myers, Djahida Bedja, Stuart D. Russell and Harikrishna Tandri and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Daniel P. Judge

214 papers receiving 15.7k citations

Hit Papers

Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in ... 2005 2026 2012 2019 2006 2005 2008 2007 2013 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome
    2006 1.3k citations Daniel P. Judge, Loretha Myers et al. profile →
  2. Marfan's syndrome
    2005 812 citations Daniel P. Judge, Harry C. Dietz profile →
  3. Angiotensin II Blockade and Aortic-Root Dilation in Marfan's Syndrome
    2008 552 citations Daniel P. Judge, Harry C. Dietz et al. profile →
  4. Angiotensin II type 1 receptor blockade attenuates TGF-β–induced failure of muscle regeneration in multiple myopathic states
    2007 542 citations Daniel P. Judge, Harry C. Dietz et al. profile →
  5. Exercise Increases Age-Related Penetrance and Arrhythmic Risk in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy–Associated Desmosomal Mutation Carriers
    2013 438 citations Cynthia A. James, Aditya Bhonsale et al. Journal of the American College of Cardiology profile →
  6. Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs
    2013 396 citations Hugh Calkins, Daniel P. Judge et al. profile →
  7. Arrhythmogenic Cardiomyopathy
    2017 278 citations Daniel P. Judge et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel P. Judge United States 66 8.9k 4.8k 4.6k 3.6k 2.1k 220 16.1k
Craig T. Basson United States 41 2.7k 0.3× 4.4k 0.9× 1.3k 0.3× 1.4k 0.4× 316 0.2× 87 7.9k
Bart Loeys Belgium 50 3.3k 0.4× 3.0k 0.6× 7.1k 1.5× 5.3k 1.5× 111 0.1× 209 11.9k
Peter L. Weissberg United Kingdom 52 1.8k 0.2× 4.2k 0.9× 1.3k 0.3× 2.1k 0.6× 301 0.1× 119 11.4k
Helena Kuivaniemi United States 57 986 0.1× 2.3k 0.5× 2.3k 0.5× 3.6k 1.0× 234 0.1× 196 9.4k
Sue Richards United Kingdom 33 2.1k 0.2× 9.6k 2.0× 8.7k 1.9× 1.6k 0.5× 105 0.1× 85 22.4k
Julie M. Gastier‐Foster United States 36 2.2k 0.2× 10.4k 2.2× 9.0k 1.9× 2.1k 0.6× 102 0.0× 122 22.8k
Nazneen Aziz United States 9 2.1k 0.2× 9.4k 2.0× 8.8k 1.9× 1.5k 0.4× 95 0.0× 9 19.7k
Paquita Nurden France 49 1.8k 0.2× 1.3k 0.3× 730 0.2× 1.1k 0.3× 627 0.3× 174 9.3k
Frederick S. Kaplan United States 64 722 0.1× 3.1k 0.7× 4.1k 0.9× 6.9k 1.9× 1.3k 0.6× 285 15.0k
Elaine Spector United States 26 2.1k 0.2× 10.1k 2.1× 9.0k 1.9× 1.5k 0.4× 90 0.0× 71 20.6k

Countries citing papers authored by Daniel P. Judge

Since Specialization
Citations

This map shows the geographic impact of Daniel P. Judge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel P. Judge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel P. Judge more than expected).

Fields of papers citing papers by Daniel P. Judge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel P. Judge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel P. Judge. The network helps show where Daniel P. Judge may publish in the future.

Co-authorship network of co-authors of Daniel P. Judge

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel P. Judge. A scholar is included among the top collaborators of Daniel P. Judge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel P. Judge. Daniel P. Judge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Telis, Natalie, Douglas Stoller, Christopher Chapman, et al.. (2025). P190: Scalable system-wide CYP2C19 pharmacogenomic testing reveals excess incidence of adverse events in metabolizers receiving inappropriate prescriptions. Genetics in Medicine Open. 3. 102155–102155. 1 indexed citations
2.
Judge, Daniel P., Kevin Alexander, Francesco Cappelli, et al.. (2025). Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid Cardiomyopathy. Journal of the American College of Cardiology. 85(10). 1003–1014. 7 indexed citations
3.
Allen, Caitlin G., Kelly J. Hunt, Lori L. McMahon, et al.. (2024). Using implementation science to evaluate a population-wide genomic screening program: Findings from the first 20,000 In Our DNA SC participants. The American Journal of Human Genetics. 111(3). 433–444. 1 indexed citations
4.
Barrett, Kelly M. Schiabor, Natalie Telis, Lisa M. McEwen, et al.. (2024). Underestimated risk of secondary complications in pathogenic and glucose-elevating GCK variant carriers with type 2 diabetes. SHILAP Revista de lepidopterología. 4(1). 239–239. 1 indexed citations
5.
García‐Pavía, Pablo, Neal K. Lakdawala, Gianfranco Sinagra, et al.. (2024). Characterization and Natural History of Patients with LMNA -Related Dilated Cardiomyopathy in the Phase 3 REALM-DCM Trial. ESC Heart Failure. 11(6). 4201–4208. 3 indexed citations
6.
Wang, Jianan, Alessio Gasperetti, Moniek G.P.J. Cox, et al.. (2024). Arrhythmogenic Cardiomyopathy: Towards Genotype Based Diagnoses and Management. Journal of Cardiovascular Electrophysiology. 36(10). 2662–2670. 3 indexed citations
7.
James, Cynthia A., Jan D.H. Jongbloed, Ray E. Hershberger, et al.. (2021). International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework. Circulation Genomic and Precision Medicine. 14(3). e003273–e003273. 110 indexed citations
8.
Gan, Peiheng, Michaela Patterson, Di Tian, et al.. (2019). Tnni3k alleles influence ventricular mononuclear diploid cardiomyocyte frequency. PLoS Genetics. 15(10). e1008354–e1008354. 26 indexed citations
9.
Gillmore, Julian D., Pablo García‐Pavía, Martha Grogan, et al.. (2019). Abstract 14214: ATTRibute-CM: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Global Phase 3 Study of AG10 in Patients With Transthyretin Amyloid Cardiomyopathy (ATTR-CM). Circulation. 5 indexed citations
10.
Judge, Daniel P., Stephen B. Heitner, Rodney H. Falk, et al.. (2019). Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid Cardiomyopathy. Journal of the American College of Cardiology. 74(3). 285–295. 180 indexed citations
11.
Caulfield, Thomas R., et al.. (2018). Protein molecular modeling techniques investigating novel TAB2 variant R347X causing cardiomyopathy and congenital heart defects in multigenerational family. Molecular Genetics & Genomic Medicine. 6(4). 666–672. 16 indexed citations
12.
Tichnell, Crystal, Weijia Wang, Brittney Murray, et al.. (2018). Performance of the 2015 International Task Force Consensus Statement Risk Stratification Algorithm for Implantable Cardioverter-Defibrillator Placement in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. Circulation Arrhythmia and Electrophysiology. 11(2). e005593–e005593. 11 indexed citations
13.
Judge, Daniel P., et al.. (2017). The Role of Genetics in Peripartum Cardiomyopathy. Journal of Cardiovascular Translational Research. 10(5-6). 437–445. 15 indexed citations
14.
Riele, Anneline S te, Cynthia A. James, Abhishek C. Sawant, et al.. (2014). Abstract 16401: Systematic Approach to Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Family Screening in a Large Transatlantic Cohort. Circulation. 130. 1 indexed citations
15.
Khella, Sami, Brian Drachman, Michael Polydefkis, et al.. (2014). Neurologic Involvement in Val-122 Ile Familial Amyloidosis (P1.026). Neurology. 82(10_supplement). 1 indexed citations
16.
Cerrone, Marina, Xianming Lin, Mingliang Zhang, et al.. (2013). Missense Mutations in Plakophilin-2 Cause Sodium Current Deficit and Associate With a Brugada Syndrome Phenotype. Circulation. 129(10). 1092–1103. 233 indexed citations
17.
Panuganti, Pradeep, Aditya Jain, Darshan Dalal, et al.. (2010). Abstract 12355: Role of Exercise Stress Testing in Arrhythmogenic Right Ventricular Dysplasia. Circulation. 122. 1 indexed citations
18.
Dalal, Darshan, Khurram Nasir, Chandra Bomma, et al.. (2005). Arrhythmogenic Right Ventricular Dysplasia. Circulation. 112(25). 3823–3832. 330 indexed citations
19.
Cheng, Alan, Loretha Myers, Francisco Martínez-Murillo, et al.. (2004). TGF-β–dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. Journal of Clinical Investigation. 114(11). 1586–1592. 360 indexed citations
20.
Cheng, Alan, Loretha Myers, Francisco Martínez-Murillo, et al.. (2004). TGF-β–dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. Journal of Clinical Investigation. 114(11). 1586–1592. 403 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Craig T. Basson Breakdown of academic impact, for papers by Bart Loeys Breakdown of academic impact, for papers by Peter L. Weissberg Breakdown of academic impact, for papers by Helena Kuivaniemi Breakdown of academic impact, for papers by Sue Richards Breakdown of academic impact, for papers by Julie M. Gastier‐Foster Breakdown of academic impact, for papers by Nazneen Aziz Breakdown of academic impact, for papers by Paquita Nurden Breakdown of academic impact, for papers by Frederick S. Kaplan Breakdown of academic impact, for papers by Elaine Spector
Rankless by CCL
2026